Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Methods in Molecular Medicine|February 23, 2011
Immunostaining human paraffin-embedded sections for mismatch repair proteinsM Mackean, R Brown
British Medical Journal (Clinical Research Ed.)|October 16, 1982
Referral routes to hospital of patients with chronic open-angle glaucomaJ M MacKean, A R Elkington
Biomedical Sciences Instrumentation|May 10, 2007
Ramped versus stepwise thermoelastic testing of latex and elastic tissuesSarah M Wells, Susan M MacKean
British Medical Journal (Clinical Research Ed.)|February 7, 1981
The quality of life after cardiac surgeryJ K Ross, J L Monro, A E Diwell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancerM Mackean, A Planting, C Twelves, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|April 15, 2020
Patterns of clinicopathological features and outcome in epithelial ovarian cancer patients: 35 years of prospectively collected dataA Irodi, T Rye, K Herbert, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 26, 2018
Diurnal profile of interstitial glucose following dexamethasone prophylaxis for chemotherapy treatment of gynaecological cancerM J Lyall, I Thethy, L Steven, et al.
British Journal of Cancer|July 2, 1999
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trialJ S Waters, A Norman, D Cunningham, et al.
British Journal of Cancer|March 20, 2014
A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancerR M Glasspool, R Brown, M E Gore, et al.
ESMO Open|April 10, 2022
Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancerM Stares, T E Ding, C Stratton, et al.
Pageof 2